resources

Investigation of subcutaneous monoclonal antibody formulations

Investigation of subcutaneous monoclonal antibody formulations

Applications Note

This content has been restricted to logged in users only.

Create an account to view resources.

Investigation of subcutaneous monoclonal antibody formulations

Applications Note

There is a strong patient preference for subcutaneous (SC) delivery of parenteral drugs. SC therapies are safer to administer and less time-consuming than intravenous (IV) therapies and they do not require supervision by medical professionals, making them suitable for self-managed home care treatments.

Previous post